Orion Oyj logo

Orion Oyj(OTC) ORINY

Market Cap$10.24BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)+275%
5 Year+157%
1 Year+20%
1 Month+1%
$46.65
+1.63%
+0.75Today
Orion Oyj last closing stock price
MetricPriceDate
Last closeUSD 46.652026-10-13
Orion Oyj stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.05%USD 46.172026-10-06
1 month+1.41%USD 46.002026-09-11
3 month+21.04%USD 38.542026-07-15
Year to date+28.37%USD 36.342025-12-29
1 year+19.81%USD 38.942025-10-13
3 year+166.26%USD 17.522023-09-29
5 year+156.63%USD 18.182021-09-03
Since inception+275.31%USD 12.432014-12-09

Orion Oyj Financials at a Glance

Market Cap

$10.24BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.06B

Net Income (TTM)

€586.88M

EPS (TTM)

$2.43

P/E Ratio

19.19

Dividend

$0.99

Beta (Volatility)

-0.06 (Low)

Price

$46.65

Volume

13

Open

$46.65

Previous Close

$46.65

Daily Range

$46.65 - $46.65

52-Week Range

$30.89 - $48.79

Estimated Earnings Date

Feb 4, 2026

ORINY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Orion Oyj

Orion Oyj is a Finnish pharmaceutical company focused on developing, producing, and marketing medicines for human and animal health. The company operates in various international markets, offering a diverse portfolio of prescription and over-the-counter products.

Products and Services
  • Prescription medications for cancer, Parkinson's disease, and heart failure
  • Over-the-counter healthcare solutions, including Easyhaler devices for respiratory conditions
  • Veterinary medications and active pharmaceutical ingredients (APIs)
Growth Outlook
  • Recent quarterly revenue reached €521.6 million, indicating strong demand
  • TTM net income margin stands at 28.5%, showcasing profitability
  • Strategic collaborations aim to enhance product offerings and market reach
Financial Highlights
  • Quarterly revenue increased by 24.8% compared to the previous quarter
  • TTM return on equity is 50%, reflecting efficient capital use
  • Dividend yield of 2.11% offers attractive returns to shareholders
Orion Oyj has established itself as a key player in the pharmaceutical industry, with a strong focus on innovation and quality. The company's diverse product range addresses critical health needs, while its strategic partnerships enhance growth potential. Recent financial performance indicates robust revenue growth and profitability, making it an intriguing option for investors interested in the healthcare sector. The commitment to research and development further positions Orion Oyj for future success in an evolving market.
AI Generated • Sep 20, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

4,235

CEO

Aino Anna Liisa Hurme, PhD

Website

www.orionpharma.com

Headquarters

Espoo, UU 02200, FI

ORINY Financials

Key Financial Metrics (TTM)

Gross Margin

65.93%

Operating Margin

35.97%

Net Income Margin

28.54%

Return on Equity

50.02%

Return on Capital

39.73%

Return on Assets

31.34%

Earnings Yield

5.21%

Dividend Yield

2.13%

Payout Ratio

41.34%

Stock Overview

Market Cap

$10.24BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

219.44M

Volume

13

Avg. Volume

582.477

Financials (TTM)

Gross Profit

€1.36B

Operating Income

€738.33M

EBITDA

€784.79M

Operating Cash Flow

€473.95M

Capital Expenditure

-€89.40M

Free Cash Flow

€384.77M

Cash & ST Invst.

€130.20M

Total Debt

€132.65M

Orion Oyj Performance Analysis

Orion Oyj annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,401,264,05614.1%
20232023-12-31EUR 1,287,933,018-8.1%
20242024-12-31EUR 1,667,318,13229.5%
20252025-12-31EUR 2,130,529,45527.8%
Orion Oyj sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.3%
Q42025-12-3164.9%
Q12026-03-31-39.9%
Q22026-06-3024.9%
Orion Oyj annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 1.3160.3%
20232023-12-31EUR 0.83-36.1%
20242024-12-31EUR 1.2752.1%
20252025-12-31EUR 2.0158.1%
Orion Oyj sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-42.4%
Q42025-12-31173.5%
Q12026-03-31-65.6%
Q22026-06-3056.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€521.60M

+25.2%

Gross Profit

€339.90M

+36.8%

Gross Margin

65.16%

N/A

Market Cap

$10.24BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.54M

N/A

Employees

4,029

N/A

Net Income

€140.20M

+69.9%

EBITDA

€191.82M

+83.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€130.20M

-29.1%

Total Debt

€132.65M

-64.5%

Accounts Receivable

€542.20M

+44.6%

Inventory

€525.30M

+19.0%

Long Term Debt

€103.36M

-35.3%

Short Term Debt

€29.29M

-86.3%

Return on Assets

31.34%

N/A

Return on Invested Capital

52.15%

N/A

Free Cash Flow

€255.90M

+393.1%

Operating Cash Flow

€274.80M

+245.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OPHLYOno Pharmaceutical Co., Ltd.
$4.65-2.31%
ALPMYAstellas Pharma Inc.
$14.35-0.14%
DSNKYDaiichi Sankyo Company, Limited
$16.56-0.24%
BIIBBiogen Inc.
$232.83+1.72%

Trending Stocks

Symbol / CompanyPricePrice Chg
BACBank of America
$51.39-4.76%
NVDANvidia
$221.30-3.16%
CRWVCoreWeave
$65.78-15.46%
INTCIntel
$98.12-4.56%

Questions About ORINY

What is the current price of Orion Oyj?

Orion Oyj is trading at $46.65 per share.

What is the 52-week range for Orion Oyj?

Over the past 52 weeks, Orion Oyj has traded between $30.89 and $48.79.

How much debt does Orion Oyj have?

As of the most recent reporting period, Orion Oyj reported total debt of €151.72M.

How much cash does Orion Oyj have on hand?

Orion Oyj reported €148.86M in cash and cash equivalents in its most recent financial results.

What is Orion Oyj’s dividend yield?

Orion Oyj currently has a dividend yield of 2.13%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services